In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | 36.4 | 36.2 | 41.2 | 40.9 | 27.5 | 23.3 | 23.6 | 23.3 |
Interest income on investments | 4.4 | 3.8 | 2.8 | 2.0 | 1.8 | 1.9 | 1.5 | 1.6 |
| 41.2 | 40.9 | 45.2 | 43.2 | 29.4 | 25.4 | 25.2 | 25.0 |
Interest expense: |
Interest on deposits | 4.0 | 6.9 | 11.0 | 7.0 | 3.8 | 2.3 | 2.4 | 2.3 |
| 14.6 | 23.7 | 35.9 | 24.1 | 6.1 | 4.2 | 4.3 | 4.3 |
Net interest income | 34.7 | 31.3 | 31.7 | 33.3 | 23.4 | 21.2 | 20.9 | 20.7 |
Provision for loan losses | 0.8 | 3.6 | 0.2 | 1.2 | 1.8 | 1.4 | 0.6 | 1.3 |
Net interest income after provision for loan losses | 33.9 | 27.7 | 31.5 | 32.1 | 21.6 | 19.8 | 20.3 | 19.4 |
Deposit and loan fees | | | | | | | 1.2 | 1.3 |
Gain on sale of investments, net | | | | | | | 0.2 | 0.0 |
Other non-interest income | 13.7 | 10.1 | 7.1 | 6.6 | 5.7 | 4.9 | 3.1 | 2.1 |
Total non-interest income | 13.7 | 10.1 | 7.1 | 6.6 | 5.7 | 4.9 | 4.5 | 3.4 |
Non-interest expenses | 34.2 | 29.7 | 27.5 | 29.5 | 19.6 | 17.1 | 16.6 | 14.9 |
Pre-tax income before non-recurring items | 14.2 | 8.4 | 11.4 | 13.1 | 8.1 | 7.9 | 8.5 | 8.1 |
Non-recurring items | 0.9 | 0.3 | 0.3 | 3.9 | 0.4 | 0.3 | 0.3 | 0.2 |
Pre-tax income | 13.3 | 8.1 | 11.1 | 9.2 | 7.7 | 7.6 | 8.2 | 7.9 |
Income taxes | 2.7 | 1.2 | 1.7 | 1.9 | 2.6 | 2.0 | 2.5 | 2.1 |
Tax rate | 20.1% | 15.3% | 15.2% | 20.2% | 33.3% | 26.5% | 30.1% | 26.8% |
Net income | 10.6 | 6.8 | 9.4 | 7.3 | 5.2 | 5.6 | 5.7 | 5.4 |
Net margin | 22.4% | 18.1% | 24.4% | 19.0% | 18.9% | 22.6% | 23.1% | 23.8% |
|
Basic EPS | $2.45 | $1.58 | $2.14 | $1.66 | $1.18 | $1.28 | $1.32 | $1.35 |
Diluted EPS | $2.44 | $1.57 | $2.11 | $1.64 | $1.16 | $1.27 | $1.30 | $1.33 |
|
Shares outstanding (basic) | 4.3 | 4.3 | 4.4 | 4.4 | 4.4 | 4.4 | 4.3 | 4.0 |
Shares outstanding (diluted) | 4.4 | 4.4 | 4.5 | 4.5 | 4.4 | 4.4 | 4.4 | 4.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |